sitagliptin price

Sitagliptin has been launched in China and has been included in medical insurance. Patients can purchase it domestically. Please consult the local hospital pharmacy for specific prices. Sitagliptin is an oral hypoglycemic drug that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is widely used in the treatment of 2 type diabetes. By inhibiting the activity of DPP-4 enzyme, it increases glucagon (GLP-1) levels, thereby regulating blood sugar. GLP-1 is a hormone released by the intestines after food intake. It can promote insulin secretion, slow down the absorption of glucose in the gastrointestinal tract, and help lower blood sugar levels. Sitagliptin is usually taken orally once daily and can be taken before or after meals, providing a convenient treatment option for people with diabetes.